STAT Plus: Indivior CEO pleads guilty in connection with a scheme to promote Suboxone

The chief executive of Indivior pleaded guilty to misbranding Suboxone Film, a medicine used to treat addiction to opioids and narcotics, one year after the company was charged with engaging in a multibillion-dollar fraudulent scheme to increase prescriptions.

Shaun Thaxter, who had led the company since 2009, was charged with misrepresentations made to a state Medicaid program about the safety of the dissolvable film strip, according to court documents. Misbranding is a broad statute that makes it a crime to mislabel a drug, fraudulently promote it, or market it for an unapproved use. He agreed to pay $600,000 in fines and faces up to one year in prison.

Continue to STAT Plus to read the full story…

Read Original Article: STAT Plus: Indivior CEO pleads guilty in connection with a scheme to promote Suboxone »